OCM
Osterweis Capital Management’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.4M | Buy |
283,208
+3,865
| +1% | +$415K | 1.46% | 28 |
|
|
2025
Q1 | $28.2M | Sell |
279,343
-52,069
| -16% | -$5.25M | 1.39% | 27 |
|
|
2024
Q4 | $29.6M | Sell |
331,412
-19,109
| -5% | -$1.71M | 1.38% | 25 |
|
|
2024
Q3 | $29.4M | Sell |
350,521
-47,822
| -12% | -$4.01M | 1.49% | 23 |
|
|
2024
Q2 | $30.7M | Sell |
398,343
-49,518
| -11% | -$3.81M | 1.59% | 22 |
|
|
2024
Q1 | $30.7M | Sell |
447,861
-77,404
| -15% | -$5.3M | 1.8% | 23 |
|
|
2023
Q4 | $30.4M | Buy |
525,265
+1,215
| +0.2% | +$70.2K | 1.93% | 21 |
|
|
2023
Q3 | $27.7M | Sell |
524,050
-22,420
| -4% | -$1.18M | 2.03% | 17 |
|
|
2023
Q2 | $29.6M | Sell |
546,470
-4,340
| -0.8% | -$235K | 1.96% | 20 |
|
|
2023
Q1 | $27.6M | Sell |
550,810
-104,155
| -16% | -$5.21M | 1.87% | 18 |
|
|
2022
Q4 | $30.3M | Buy |
654,965
+1,355
| +0.2% | +$62.7K | 2.2% | 11 |
|
|
2022
Q3 | $25.3M | Sell |
653,610
-26,065
| -4% | -$1.01M | 1.9% | 15 |
|
|
2022
Q2 | $25.3M | Buy |
679,675
+153,700
| +29% | +$5.73M | 1.9% | 18 |
|
|
2022
Q1 | $23.3M | Buy |
525,975
+3,415
| +0.7% | +$151K | 1.28% | 22 |
|
|
2021
Q4 | $22.2M | Buy |
522,560
+20,790
| +4% | +$883K | 1.11% | 29 |
|
|
2021
Q3 | $21.8M | Buy |
+501,770
| New | +$21.8M | 1.19% | 29 |
|